chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pneumo vaccine was given at 11:30am on 10-13-07 in the right arm.  At 4:30pm on the same day, the pharmacy received a call from the patient complaining of severe soreness in the right arm and stating that the arm was "useless" and that she was unable to move it.  There was no swelling, difficulty breathing or fever reported.
Rash, skin eruption on upper part of the body starting from waist up. Itching and red started at night.
This spontaneous report as received from a licensed practical nurse refers to a female patient of unknown age. On an unknown dates (reported as at age-appropriate times), the patient received two doses of VARIVAX (Merck) (dose, route, anatomical location, lot # and expiration date were not reported). On an unknown date (reported as one month after), the patient experienced varicella-like rash. The reporting nurse did not think that varicella-like rash was confirmed by medical examination. The outcome of varicella-like rash was unknown. The relatedness between the event and the vaccination with VARIVAX (Merck) was not provided. This is the one of the several reports from the same reporter source. Additional information has been requested.
PATIENT GOT PEDIATRIC DOSE (ENGERIX-B 10MCG ) INSTEAD OF ADULT DOSE (ENGERIX-B 20MCG) FOR HER FIRST DOSE . PATIENT HAS NO ADVERSE REACTIONS.
After receiving the shot, felt the normal effects within one day - tired, joint aches, headaches, chills, and sore arm.  By on the morning of the fourth day began feeling tightness in the calf and by the evening pain and cramping like feeling in the right calf in the back.   The following day felt extreme pain, tightness in the calf, and swelling.  Went to the emergency room that night for pain.   The result was a blood clot in lower right leg.
Adverse reaction started at approximately 1030pm about 8 hours after receiving the vaccine. I started to shake and took my temperature to find that I had 104.6 fever and took Tylenol 1000mg and tried to go to sleep. About 30 minutes later at 11pm I vomited so I went to talk to my parents. They took my temperature and it spiked to 106.7 knowing I had already taken Tylenol they grabbed ice packs and wrapped them in a towel and placed them under my armpits and behind my neck they also placed a damp cloth on my forehead and monitored my fever. At around 1145  my fever started to come down slowly to 104.2. Around 130am I ate a few crackers and took ibuprofen 600mg and the fever still slowly dropped at around 2am my fever was still at 102.4 at this time my  parents went to bed knowing that my body needed to continue to fight the fever. At 530am my father checked my temperature and it was normal.
Developed rash on Left arm near injection site, spreads to back.  Rash was noticed the morning after the injection.  Itches.  Rash described as fine blanching macular/papular
After first dose had extreme fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 28 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in arm left, administration date 04Mar2021 12:15 (Batch/Lot number: unknown) at the age of 28 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (unspecified if ongoing); "Depression" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION; BUSPIRONE; PRILOSEC [OMEPRAZOLE]; DOXEPIN. The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "recovering", described as "After first dose had extreme fatigue". Therapeutic measures were not taken as a result of fatigue. Additional information: The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After the vaccine, I felt tired as I expected. Around 8:00 that night I got a very bad headache and went to bed. I woke up at 2:00am to horrid abdominal pain. It lasted about 3 hours and during that time, I could not walk or catch my breath. I figured it was a one time reaction. After that night, I had multiple times where I would double over and not be able to walk or talk. In the first week after the shot I lost 11 pounds. I continued to have daily headaches for 6 weeks after. 2 years ago my dr's found that I had a gallstone after some imaging done of my kidneys. It had never bothered me, until hours after getting the vaccine. My doctors felt the shot brough on inflammation which triggered an underlying issue (gallstones). With a low fat diet, acupuncture and time my gallbladder attacks happened less frequently until 7/13. I had a horrid gallbladder attack and it landed me in the Emergency Room. I have a surgical consult scheduled for 8/10 to have my gallbladder removed. I am down to 104 pounds. My joints are all very sore from my strict diet and Ehlers Danlos.
02/04/2022 During a routine outpatient visit my uranalysis showed I had a bladder infection and that I had it for quite some time. I was given antibiotics amoxicillin which I forgot I was not supposed to take and it made me sick. Also was given clindamycin for 9 days and I had a cat bite I was taking it for as well as the bladder infection. The antibiotics did the trick and I was cleared from my bladder infection. Also, I am still healing from my cat bite but it is greatly reduced in pain and redness. Should make full recovery soon.
6/20/2022 PCR test, results in 6/21 test positive.  6/22 saw a health doctor and they prescribed Paxlovid. Just muscle aches on 6/22. 6/23 Sore throat, painful to swallow, difficulty sleeping at night. Symptoms improved until Paxlovid all taken. 6/27 Runny eyes and runny nose, fatigue, difficulty concentration. These continue up to time of reporting.
Flare up of Parsonage-Turner syndrome symptoms.  Numbness, parasthesias and weakness in left arm and hand.
severe low back pain; difficulty walking; difficulty standing; difficulty sitting; This is a spontaneous report from a contactable Other Health Professional.  A 50-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL0140), intramuscularly in the left arm on 30Dec2020 at 15:30 at 50-years-old at a single dose for COVID-19 immunization; administered in a living facility. The patient did not have COVID-19 prior to the vaccination. The patient's medical history was reported as NONE. Concomitant medication included colecalciferol (VITAMIN D) taken for an unspecified indication from an unspecified date to an unspecified date; and an unspecified vaccine (SEQIRUS; Lot Number: P 100242861) taken for an unspecified indication on 01Dec2020. On 03Jan2021 at 10:00, the patient experienced severe low back pain (non-serious), difficulty walking (non-serious), difficulty standing (non-serious), difficulty sitting (non-serious); for which no treatment was given. Four days after the injection, the patient had severe low back pain. The patient had difficulty walking, standing, sitting. After the first injection the pain was bad for 3-4 days, and then was gone after 7 days. The patient underwent lab tests and procedures which included COVID test: negative on 21Jan2021. The clinical outcome of the events was recovered on an unspecified date (as reported). The patient received the second dose of the bnt162b2 (Lot Number: 123302), on 20Jan2021 in the left arm.
First night following vax,pt had swelling at inj site & high-pitched screaming for hrs.2 wks later,began having complex partial seizures.7 wks later,began having prolonged seizures on reg. basis.She is severely delayed & dvlped eczema. Annual followup indicates pt died on 12/5/2000. She continued to have serious seizures and developmental delays and sensory integration problems. Her seizures stopped for almost 2 years with the ketogenic diet. Then they started again and she had her last big one, her brain swelled and she died.
Patient returned to clinic on 2/19/08 for an IPV for foreign travel and verbally reports that the oral Typhoid I sent him home with on 2/3/08 caused a complete body rash and itching.
Severe pain in shoulder, fever. Headache, weakness, cough, shaking, shivers.
Narrative:  81yo M with stage IV cancer - multiple new cancer diagnoses on 6/29/21 died at home on 8/6/2021 in community care home health care. Pt had received covid vaccinations on 2/6/21 & 2/27/21 from non-agency hospital. Death appears not related to vaccinations.
Patient started having itchy throat, feeling of warmth throughout entire body. within 10 minutes of getting first dose pfizer vaccination
Pt pale and diaphoretic, unable to speak for a few seconds, with shallow resp.  911 called  Laid down on cot bed, obtained vs, and monitored pt. until paramedics arrived on scene.   Pt evaluated returned to baseline with VSS on RA, released to mother, who took pt to urgent care for further evaluation via private vehicle
getting genital herpes after the vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of genital herpes in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced genital herpes. On an unknown date, the outcome of the genital herpes was unknown.   It was unknown if the reporter considered the genital herpes to be related to Shingrix.     Additional Information: GSK Receipt Date: 15-AUG-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient asked was there a risk of getting genital herpes after getting the Shingrix vaccine it happened to him/her for the for the first time. Additional supportive information: The follow-up would not possible, as no contact, details were available.
Severe sepsis due to complicated UTI from indwelling suprapubic catheter. Has been treated with IV fluids. Was initially on Rocephin >> switched to Cipro after urine culture resulted. Patient will complete 14-day course of Cipro. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Extreme chills (bone chill) alternating with sweats. Sore arm, swollen lymph node underarm. Vivid dreams/nightmares that significantly impacted sleep
Approximately 7 days after HPV IM, L deltoid became very sore, painful to abduct. Nosig soreness at 24 hours after IM. On exam is tender deep in muscle and is enlarged. No surface redness. No induration.
Pain, redness, swelling, headache, tiredness, hausea, diarrhea, stomach ache, chills, body aches, sore joints, rash, fever, paleness, dizziness.  On set of symtoms approximately 12 hours after injection.  Doctor precribed Benydryl for swelling and reddness at site of injection.
Pt stated she has a 2" wide and 1 1/2" long rash around injection site, soreness, and she cannot bend her arm after her flu shot on Sunday 9/15/13. She asked to report this to FDA.
IMMUNIZATION WAS GIVEN ON 09/17/2008, ON 09/18/2008 CLIENTS INJECTION SITE BEGAN TO ITCH AND BURN, THEN PROGRESSED TO REDNESS 3 INCHES X 5 INCHES WITH WHITE PERIMETER.  ON SATURDAY 09/20/2008 CLIENT ICED AREA AND TOOK BENEDRYL 50 MG TWICE.  ON 09/21/2008, SHE AGAIN ICED IT AND TOOK ONE DOSE OF BENEDRYL 50 MG AND LATER A DOSE OF 25 MG.  SHE REPORTS THE REACTION IS SUBSIDING ON 09/22/2008 WITH REDNESS AND SLIGHT INDURATION NOTED 53 MM X 23 MM.  THERE IS A PINK AREA WITH NO INDURATION OUT TO 35 MM.
Patient received first dose of covid by Moderna and received second dose by Pfizer on 05-12-2021
He states eight days after he received his first COVID vaccine he broke out in a itchy rash on both arms, around his waist and groin area, chest, and abdomen as well as his left ankle area.  He states he was working in his yard on Saturday, 03/27/2021. but states he didn't come in contact with any poison ivy that he is aware of.  He states he has been taking Benadryl and Claritin OTC. He was prescribed a steroid dose pack for the itching today, 04/05/2021. He called VAERS on 04/05/2021,  and left a message for them to call him back.
102 fever, chills, loss of appetite,extreme body weakness, loss of taste, vomiting
This spontaneous report was received from a healthcare worker regarding unspecified number of patients of unknown age and gender. There was no information on pertinent medical history and drug reactions or allergies. On an unknown date, the patients were vaccinated with doses of GARDASIL that were improperly stored (dose, product lot#, expiry date not reported). No adverse experiences were reported until 01-APR-2015. There was no product quality complaint involved. The outcome of the events was unknown. This is one of several reports from the same source. Additional information has been requested.
mild dry mouth; felt a little foggy; This is a spontaneous report from contactable consumer via a Pfizer Sales Representative. A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 18Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced mild dry mouth and felt a little foggy on 18Dec2020. The clinical outcome of mild dry mouth and felt a little foggy was recovered on 18Dec2020.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Received vaccine from a vial that was punctured and left at room temperature for 48 hours; Punctured vial left out room temperature was given to 5 people; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Received vaccine from a vial that was punctured and left at room temperature for 48 hours) and POOR QUALITY PRODUCT ADMINISTERED (Punctured vial left out room temperature was given to 5 people) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PRODUCT STORAGE ERROR (Received vaccine from a vial that was punctured and left at room temperature for 48 hours) and POOR QUALITY PRODUCT ADMINISTERED (Punctured vial left out room temperature was given to 5 people). On 10-Mar-2021, PRODUCT STORAGE ERROR (Received vaccine from a vial that was punctured and left at room temperature for 48 hours) and POOR QUALITY PRODUCT ADMINISTERED (Punctured vial left out room temperature was given to 5 people) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Presented to the ED on 9/13/21 from the nursing home after his SpO2 saturations were found to be 81%. Patient tested positive for COVID on 9/5/2021. Patient received both series of Moderna Vaccine, completed on 4/15/21. -COVID positive, CT of chest showed no sign of PE, nonspecific patchy areas of ground-glass opacification with bilateral upper lobe predominance not typically a feature of COVID-19 involvement.  Chronic bronchiectatic changes with superimposed atelectasis along the periphery of the bilateral lower lobes. -WBC 8.06, lactic 1.45, procal 0.27 -ABG: pO2 52.4, pCO2 23.7, pH 7.45 -Initiate COVID protocol -Prophylactically start on doxycycline and ceftriaxone -Blood cultures x2 pending, continue to follow -Patient received 125 solumedrol in route to ED, will continue with dexamethasone Q6H -Supplemental O2 to maintain saturations >92%, currently saturating 94% on 2L. On admission 9/13/21, pt was treated with IV antibiotics, IV Decadron and low maintenance IVF.  On 9/15/21 Remdesivir was started. ID consulted for methicillin resistant staph coagulase negative bacteremia.  Antibiotics Switched from Doxycycline to Vancomycin.  Final Repeat Blood cultures from 9/18 were negative. IV line continued to blow, so IV Vancomycin switched to Oral Zyvox on 9/25/21.  ID recommending to continue for 1 week after discharge. Discharged on 9/30/21
Extreme pain, crying, unconsolable, would stretch out and shake violently and grunt while staring with wide eyes that looked horrified. Diarrhea and lessening of bowel movements. Loss of appetite with fewer and shorter length of time of nursing periods
After receiving each Moderna dose, I developed oral lesions, on my gums, which resemble canker sores, but do not cause pain. The lesions are slightly darker than the normal color of my gum tissue, and most appear to have at least one spot of white in the center. At current count, there appear to be six distinct lesions.
Started with muscle aches and headache progressed to severe chills and shaking. Dizziness and feeling of passing out the next morning
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: called 911 but patient recovered before paramedix arrived
INJECTION SITE RED, WARM SWOLLEN.  HE WENT TO THE ER AND WAS GIVEN KEFLEX WITH A CELLULITIS DIAGNOSIS. TODAY IN THE OFFICE THE AREA IS 17CM X 11 CM.  IT IS LESS WARM AND LESS SWOLLEN AND LESS FIRM TODAY PER MOM.
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported. On 19-DEC-2018, the patient was vaccinated with improperly stored VAQTA (lot # R013858, expiration date: 12-JUN-2019, strength, dose, frequency and route were unknown) for prophylaxis (Incorrect product storage). No adverse effects were reported. The vaccines were exposed to temperature of 47 Fahrenheit (F) for 37 minutes. The temperature excursion was detected by a data logger. Previous temperature excursions were reported as 47 Fahrenheit (F) for 50 minutes. The case was one of the cases received from the same reporter. Sender's Comments: US-009507513-1901USA004786.
Blotchy rash; Raised rash; Pain at injection site.; This case was reported by a consumer via call center representative and described the occurrence of blotchy rash in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd April 2019, the patient received the 1st dose of Shingrix. On 24th April 2019, 2 days after receiving Shingrix, the patient experienced blotchy rash, raised rash and injection site pain. On an unknown date, the outcome of the blotchy rash, raised rash and injection site pain were unknown.   It was unknown if the reporter considered the blotchy rash, raised rash and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient called to report that she received Shingrix, and 2 days later experienced blotchy raised rash, and pain at injection site. The patient did not have lot number or expiration date.
Varicella scattered erythematous, macules with central vesicular and pruritus. TX Benadryl.
pain in arm; arm felt heavy; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced INSOMNIA (could not sleep). At the time of the report, INSOMNIA (could not sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included diabetes medication unspecified. No treatment information was provided.   This case was linked to MOD-2021-080632, MOD-2021-015804 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: Information on dose 2 was provided. On 19-Apr-2021: Reporter's contact information was updated.
The patient got dizzy, lightheaded, nauseous, and had a synoptical episode. The patient did not hit their head or fall during episode. The patient was sitting on their father's lap when he felt faint and passed out. I went and got the provider that the patient was assigned to, and she began her assessment. We laid the patient on exam table while the provider assessed the patient. The patient was given water as well as a cold compress on his neck and head. The patient was closely watched until patient was comfortable and walked out by provider. This situation lasted approximately 15 minutes.